Needham analyst Joseph Stringer assigned a Buy rating to Cara Therapeutics (CARA) today and set a price target of $26.00.
The post Needham Gives a Buy Rating to Cara Therapeutics (CARA) appeared first on Smarter Analyst.
Needham analyst Joseph Stringer assigned a Buy rating to Cara Therapeutics (...

https://www.smarteranalyst.com/new-blurbs/needham-gives-a-buy-rating-to-cara-therapeutics-cara/

#SmarterAnalyst